Evofem Biosciences Inc (NASDAQ:EVFM)

1.09
BATS BZX Real-Time Price
As of 3:50pm ET
 +0.1783 / +19.66%
Today’s Change
0.28
Today|||52-Week Range
15.90
-80.74%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$43.4M

Company Description

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.

Contact Information

Evofem Biosciences, Inc.
12400 High Bluff Drive
San Diego California 92130
P:(858) 550-1900
Investor Relations:
18585501900167

Employees

Shareholders

Other institutional5.86%
Mutual fund holders4.47%
Individual stakeholders1.99%

Top Executives

Saundra L. PelletierChairman, President & Chief Executive Officer
Justin J. FileChief Financial Officer
Brandi HowardHead-Medical Affairs
Bret HenningSenior Director-Information Technology
Alexander A. FitzpatrickSecretary, Executive VP & General Counsel